+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceutical Continuous Manufacturing Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product; Application; End User and Geography

  • ID: 5023748
  • Report
  • April 2020
  • Region: Global
  • 239 pages
  • The Insight Partners
UP TO OFF
until Sep 30th 2020
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • ACG
  • Coperion GmbH
  • Freund-vector Corporation
  • Gericke AG
  • Hosokawa Micron Group
  • Korsch AG
  • MORE
The pharmaceutical continuous manufacturing market is expected to reach US$ 3,064.38 million by 2027 from US$ 1,459.53 million in 2019. The market is estimated to grow at a CAGR of 9.8% from 2020 to 2027.

The growth of the market is attributed to key driving factors such as increasing shortage of medicines and advantages offered by continuous manufacturing process. However, high capital costs required for the establishment of these systems expected to restrain the growth of the market during the forecast period.

Batch manufacturing have been the most common and traditionally used mode of manufacturing in the pharmaceuticals industry for more than a century. However, with the rising demand for biologics and increasing trend of contract manufacturing, the flexible manufacturing alternatives such as continuous manufacturing processes are being embraced and gaining importance in the recent years. The FDA is passing quick approvals to companies transitioning from batch production to continuous manufacturing procedures. In 2016, Orkambi by Vertex Pharmaceuticals was the first manufacturer to go “batch-less” on their production lines. Furthermore, in April 2019, Janssen Pharmaceuticals, a division of Johnson & Johnson Services, Inc., switched to continuous manufacturing process for the development of active pharmaceutical ingredients (API) due to the advantages offered by this process in terms of streamlining the manufacturing procedure and ability to accelerate procedures. Continuous pharmaceutical manufacturing involves a drug taken from its base ingredients to final product with no need of halt or stop during the production. According to the Food and Drug Administration (FDA), the pharmaceutical manufacturing industry wastes up to US$ 50 billion every year on an average on inefficient processes. Continuous manufacturing serves to be a potential solution for the same problem. In addition, there are various other advantages offered by the continuous process that include more time-efficiency, reduced energy needs, and increased productivity, as well as reduction in overall wastage amounts. Furthermore, the risk of human error is also reduced in the continuous process due to a smaller number of people involved in the manufacturing process. Thus, the advantages offered by continuous manufacturing over batch manufacturing procedure are expected to drive the growth of the market over the coming years.

The global pharmaceutical continuous manufacturing market is segmented into product, application, end user, and geography. The pharmaceutical continuous manufacturing market, by product, is segmented into integrated systems, semi-continuous systems, and controls. In 2019, the integrated systems segment accounted for the largest market share of the global pharmaceutical continuous manufacturing market. The integrated systems are expected to dominate the product segment owing to their easy availability and accessibility as well as higher adoption of these systems as compared with the semi-continuous systems and the controls. The integrated systems help build the continuous flow during manufacturing process, facilitate end-to-end integration, and improve asset utilization. Based on application, the market is segmented into end product manufacturing and API manufacturing. Based on end user, the market is segmented into full-scale manufacturing companies and R& D departments.

Some of the crucial secondary sources included in the report are Food and Drug Administration, World Health Organization (WHO), Organization for Economic Co-operation and Development, Rashtriya Swasthya Bima Yojna, Health Canada, and European Medical Agency (EMA).

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the pharmaceutical continuous manufacturing market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global pharmaceutical continuous manufacturing market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • ACG
  • Coperion GmbH
  • Freund-vector Corporation
  • Gericke AG
  • Hosokawa Micron Group
  • Korsch AG
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Pharmaceutical Continuous Manufacturing Market - By Product
1.3.2 Global Pharmaceutical Continuous Manufacturing Market - By Application
1.3.3 Global Pharmaceutical Continuous Manufacturing Market - By End User
1.3.4 Global Pharmaceutical Continuous Manufacturing Market - By Geography

2. Pharmaceutical Continuous Manufacturing Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Pharmaceutical Continuous Manufacturing - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America
4.2.2 Europe
4.2.3 Asia Pacific
4.2.4 Middle East & Africa
4.2.5 South and Central America
4.3 Expert Opinion

5. Global Pharmaceutical Continuous Manufacturing Market - Industry Dynamics
5.1 Key Drivers
5.1.1 Increasing Shortage of Medicines
5.1.2 Advantages Offered by Continuous Manufacturing Process
5.2 Key Market Restraints
5.2.1 High Capital Investments
5.3 Key Market Opportunities
5.3.1 Emerging Markets
5.4 Future Trends
5.4.1 Increasing Adoption of Continuous Manufacturing in Pharmaceuticals
5.5 Impact Analysis

6. Pharmaceutical Continuous Manufacturing Market - Global Analysis
6.1 Global Pharmaceutical Continuous Manufacturing Market Revenue Forecast And Analysis
6.2 Global Pharmaceutical Continuous Manufacturing Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players

7. Pharmaceutical Continuous Manufacturing Market Analysis - By Product
7.1 Overview
7.2 Pharmaceutical Continuous Manufacturing Market Share, by Product, 2019 and 2027 (%)
7.3 Integrated Systems
7.3.1 Overview
7.3.2 Integrated Systems: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.4 Semi-Continuous Systems
7.4.1 Overview
7.4.2 Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.4.3 Continuous Granulators
7.4.3.1 Overview
7.4.3.2 Continuous Granulators: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.4.4 Continuous Blenders
7.4.4.1 Overview
7.4.4.2 Continuous Blenders: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.4.5 Continuous Compressors
7.4.5.1 Overview
7.4.5.2 Continuous Compressors: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.4.6 Continuous Coaters
7.4.6.1 Overview
7.4.6.2 Continuous Coaters: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.4.7 Continuous Dryers
7.4.7.1 Overview
7.4.7.2 Continuous Dryers: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.4.8 Other Semi-Continuous Systems
7.4.8.1 Overview
7.4.8.2 Other Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.5 Controls
7.5.1 Overview
7.5.2 Controls: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)

8. Pharmaceutical Continuous Manufacturing Market- By Application
8.1 Overview
8.2 Pharmaceutical Continuous Manufacturing Market Share, by Application, 2019 and 2027 (%)
8.3 End Product Manufacturing
8.3.1 Overview
8.3.2 End Product Manufacturing: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
8.3.3 Solid Dosage Manufacturing
8.3.3.1 Overview
8.3.3.2 Solid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
8.3.4 Liquid Dosage Manufacturing
8.3.4.1 Overview
8.3.4.2 Liquid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
8.4 API Manufacturing
8.4.1 Overview
8.4.2 API Manufacturing: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)

9. Pharmaceutical Continuous Manufacturing Market - By End User
9.1 Overview
9.2 Pharmaceutical Continuous Manufacturing Market Share, by End User, 2019 and 2027 (%)
9.3 Full-Scale Manufacturing Companies
9.3.1 Overview
9.3.2 Full-Scale Manufacturing Companies: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
9.3.3 Pharmaceutical Companies
9.3.3.1 Overview
9.3.3.2 Pharmaceutical Companies: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
9.3.4 Contract Manufacturing Organizations
9.3.4.1 Overview
9.3.4.2 Contract Manufacturing Organizations: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
9.4 R&D Departments
9.4.1 Overview
9.4.2 R&D Departments: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
9.4.3 Contract Research Organizations
9.4.3.1 Overview
9.4.3.2 Contract Research Organizations: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)
9.4.4 Research Institutes
9.4.4.1 Overview
9.4.4.2 Research Institutes: Pharmaceutical Continuous Manufacturing Market- Revenue and Forecast to 2027 (US$ million)

10. Pharmaceutical Continuous Manufacturing Market - Geographic Analysis
10.1.1 Overview
10.1.2 North America: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.1.3.1 North America: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.1.4 North America: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.1.4.1 North America: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.1.5 North America: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.1.5.1 North America: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.1.5.2 North America: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.1.6 North America: Pharmaceutical Continuous Manufacturing Market, by Country, 2019 & 2027 (%)
10.1.7 US: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.1.7.2.1 US: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.1.7.3 US: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.1.7.3.1 US: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.1.7.4 US: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.1.7.4.1 US: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.1.7.4.2 US: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.1.8 Canada: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.1.8.2.1 Canada: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.1.8.3 Canada: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.1.8.3.1 Canada: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.1.8.4 Canada: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.1.8.4.1 Canada: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.1.8.4.2 Canada: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.1.9 Mexico: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.1.9.2.1 Mexico: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.1.9.3 Mexico: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.1.9.3.1 Mexico: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.1.9.4 Mexico: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.1.9.4.1 Mexico: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.1.9.4.2 Mexico: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.2 Europe: Pharmaceutical Continuous Manufacturing Market
10.2.1 Overview
10.2.2 Europe: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.2.3.1 Europe: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.2.4 Europe: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.2.4.1 Europe: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.2.5 Europe: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.2.5.1 Europe: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.2.5.2 Europe: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.2.6 Europe: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)
10.2.7 Germany: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.2.7.2.1 Germany: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.2.7.3 Germany: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.2.7.3.1 Germany: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.2.7.4 Germany: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.2.7.4.1 Germany: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.2.7.4.2 Germany: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.2.8 UK: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.2.8.1 UK: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.2.8.2 UK: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.2.8.2.1 UK: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.2.8.3 UK: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.2.8.3.1 UK: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.2.8.4 UK: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.2.8.4.1 UK: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.2.8.4.2 UK: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.2.9 France: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.2.9.1 France: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.2.9.2 France: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.2.9.2.1 France: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.2.9.3 France: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.2.9.3.1 France: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.2.9.4 France: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.2.9.4.1 France: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.2.9.4.2 France: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.2.10 Spain: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Spain: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Spain: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.2.10.2.1 Spain: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.2.10.3 Spain: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.2.10.3.1 Spain: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.2.10.4 Spain: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.2.10.4.1 Spain: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.2.10.4.2 Spain: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.2.11 Italy: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Italy: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Italy: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.2.11.2.1 Italy: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.2.11.3 Italy: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.2.11.3.1 Italy: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.2.11.4 Italy: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.2.11.4.1 Italy: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.2.11.4.2 Italy: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.3 Asia Pacific: Pharmaceutical Continuous Manufacturing Market
10.3.1 Overview
10.3.2 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.3.2.1 Asia Pacific: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.3.3 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.3.3.1 Asia Pacific: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.3.4 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.3.4.1 Asia Pacific: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.3.4.2 Asia Pacific: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.3.5 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)
10.3.6 China: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.3.6.1 China: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.3.6.1.1 China: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.3.6.2 China: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.3.6.2.1 China: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.3.6.3 China: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.3.6.3.1 China: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.3.6.3.2 China: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.3.7 Japan: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.3.7.1 Japan: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.3.7.1.1 Japan: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.3.7.2 Japan: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.3.7.2.1 Japan: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.3.7.3 Japan: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.3.7.3.1 Japan: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.3.7.3.2 Japan: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.3.8 India: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.3.8.1 India: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.3.8.2 India: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.3.8.2.1 India: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.3.8.3 India: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.3.8.3.1 India: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.3.8.4 India: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.3.8.4.1 India: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.3.8.4.2 India: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.3.9 South Korea: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.3.9.1 South Korea: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.3.9.2 South Korea: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.3.9.2.1 South Korea: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.3.9.3 South Korea: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.3.9.3.1 South Korea: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.3.9.4 South Korea: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.3.9.4.1 South Korea: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.3.9.4.2 South Korea: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.3.10 Australia: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.3.10.1 Australia: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.3.10.2 Australia: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.3.10.2.1 Australia: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.3.10.3 Australia: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.3.10.3.1 Australia: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.3.10.4 Australia: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.3.10.4.1 Australia: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.3.10.4.2 Australia: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.4 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market
10.4.1 Overview
10.4.2 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.4.3 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.4.3.1 Middle East & Africa: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.4.4 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.4.4.1 Middle East & Africa: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.4.5 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.4.5.1 Middle East & Africa: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.4.5.2 Middle East & Africa: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.4.6 Middle East & Africa: Pharmaceutical Continuous Manufacturing Market Share by Country - 2019 & 2027, (%)
10.4.7 Saudi Arabia: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Saudi Arabia: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Saudi Arabia: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.4.7.2.1 Saudi Arabia: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.4.7.3 Saudi Arabia: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.4.7.3.1 Saudi Arabia: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.4.7.4 Saudi Arabia: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.4.7.4.1 Saudi Arabia: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.4.7.4.2 Saudi Arabia: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.4.8 UAE: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.4.8.1 UAE: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.4.8.2 UAE: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.4.8.2.1 UAE: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.4.8.3 UAE: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.4.8.3.1 UAE: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.4.8.4 UAE: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.4.8.4.1 UAE: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.4.8.4.2 UAE: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.4.9 South Africa: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
10.4.9.1 South Africa: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.4.9.2 South Africa: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.4.9.2.1 South Africa: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.4.9.3 South Africa: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.4.9.3.1 South Africa: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.4.9.4 South Africa: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.4.9.4.1 South Africa: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.4.9.4.2 South Africa: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.5 South and Central America: Pharmaceutical Continuous Manufacturing Market
10.5.1 Overview
10.5.2 South and Central America: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
10.5.3 South and Central America: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.5.3.1 South and Central America: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.5.4 South and Central America: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.5.4.1 South and Central America: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.5.5 South and Central America: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.5.5.1 South and Central America: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.5.5.2 South and Central America: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.5.6 South and Central America: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)
10.5.7 Brazil: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Brazil: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.5.7.2.1 Brazil: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.5.7.3 Brazil: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.5.7.3.1 Brazil: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.5.7.4 Brazil: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.5.7.4.1 Brazil: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.5.7.4.2 Brazil: R&D Departments Market, by Type, 2018-2027 (USD Million)
10.5.8 Argentina: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.5.8.1 Argentina: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.5.8.2 Argentina: Pharmaceutical Continuous Manufacturing Market, by Product, 2018-2027 (USD Million)
10.5.8.2.1 Argentina: Semi-Continuous Systems Market, by Type, 2018-2027 (USD Million)
10.5.8.3 Argentina: Pharmaceutical Continuous Manufacturing Market, by Application, 2018-2027 (USD Million)
10.5.8.3.1 Argentina: End Product Manufacturing Market, by Type, 2018-2027 (USD Million)
10.5.8.4 Argentina: Pharmaceutical Continuous Manufacturing Market, by End User, 2018-2027 (USD Million)
10.5.8.4.1 Argentina: Full-Scale Manufacturing Companies Market, by Type, 2018-2027 (USD Million)
10.5.8.4.2 Argentina: R&D Departments Market, by Type, 2018-2027 (USD Million)

11. Impact of COVID-19 Pandemic on Global Pharmaceutical Continuous Manufacturing Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of World: Impact Assessment of COVID-19 Pandemic

12. Pharmaceutical Continuous Manufacturing Market -Industry Landscape
12.1 Overview
12.2 Growth Strategies
12.2.1 Overview

13. Company Profiles
13.1 GEA Group
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Coperion GmbH
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Gericke AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Glatt GmbH
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Hosokawa Micron Group
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Munson Machinery Co., Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Powrex Corp
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 THERMO FISHER SCIENTIFIC INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 ACG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Cadmach Machinery Co. Pvt. Ltd.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Fette Compacting
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Freund-Vector Corporation
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 KORSCH AG
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 LEISTRITZ AG
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 ALEXANDERWERK AG
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 Hovione
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments

14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms
Note: Product cover images may vary from those shown
3 of 3
  • GEA Group
  • Coperion GmbH
  • Gericke AG
  • Glatt GmbH
  • Hosokawa Micron Group
  • Munson Machinery Co. Inc.
  • Powrex Corp
  • Thermo Fisher Scientific Inc.
  • Freund-vector Corporation
  • Fette Compacting
  • Alexanderwerk
  • Leistritz AG
  • Korsch AG
  • ACG
  • Cadmach Machinery Co. Pvt. Ltd.
  • Hovione en Aesica
Note: Product cover images may vary from those shown
Adroll
adroll